The results of the meta-analysis suggested that the use of albumin increased the risk of death by 6% compared to using other types of intravenous solutions. It was however unclear whether the administration of albumin could be responsible for these deaths and to understand how it could be dangerous. It was then reported to health professionals that more research on the use of albumin was necessary, and were reminded to follow the letter the recommendations contained in the documents information on authorized products when they had to use albumin.

Search terms for this article: